SCHEMBL28151194

SCHEMBL28151194

Cc1cc(C)cc(-c2cc(NCc3ccc(N(C)C)cc3)nc(N)n2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.49
▸ RAB9A P51151 3/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ KDM4E B2RXH2 5/20 0.46
▸ ALDH1A1 P00352 5/20 0.46
▸ CYP1A2 P05177 5/20 0.46
▸ CYP3A4 P08684 5/20 0.46
▸ MAPT P10636 5/20 0.46
▸ HPGD P15428 5/20 0.46
▸ HSD17B10 Q99714 5/20 0.46
▸ SMN1; SMN2 Q16637 5/20 0.46
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ TP53 P04637 4/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ SYK P43405 1/20 0.46
▸ CYP2C19 P33261 4/20 0.46
▸ HIF1A Q16665 2/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ GLA P06280 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28152251 0.81 CA1 (0.55) NPC1RAB9A
SCHEMBL28043938 0.81 PTGS2 (0.54) —
SCHEMBL15757592 0.79 NUDT1 (0.59) NPC1RAB9AL3MBTL1KDM4EALDH1A1
SCHEMBL28043723 0.78 HRH4 (0.63) HRH4
SCHEMBL28151149 0.77 HRH4 (0.64) CYP2C19HRH4CYP2D6TLR8AURKA
SCHEMBL28151182 0.76 HRH4 (0.52) ALDH1A1SMN1; SMN2HRH4PTGDRTLR8
SCHEMBL28043889 0.76 TGFBR1 (0.43) RAB9AKDM4EALDH1A1CYP1A2MAPT
SCHEMBL28043772 0.76 AURKA (0.54) HRH4NOS1TLR8AURKAPDPK1
SCHEMBL28043933 0.74 HRH4 (0.50) ALDH1A1SMN1; SMN2HRH4PTGDRTLR8
SCHEMBL28043930 0.73 HRH4 (0.55) SMN1; SMN2CYP2C19HRH4CYP2D6TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 — — CN disclosed
CN-106794181-A MTH1 inhibitors for the treatment of inflammatory and autoimmune conditions 托马斯·黑勒戴药物研究基金会 2017-05-31 — — CN disclosed
CN-105143206-A Pyrimidine-2,4-diamine derivatives for treatment of cancer THOMAS HELLEDAYS STIFTELSE F R MEDICINSK FORSKNING 2015-12-09 — — CN disclosed
Send feedback